These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 12076870)

  • 1. Histological and virological features and follow-up of hepatitis C virus carriers with normal aminotransferase levels: the Italian prospective study of the asymptomatic C carriers (ISACC).
    Puoti C; Castellacci R; Montagnese F; Zaltron S; Stornaiuolo G; Bergami N; Bellis L; Precone DF; Corvisieri P; Puoti M; Minola E; Gaeta GB
    J Hepatol; 2002 Jul; 37(1):117-23. PubMed ID: 12076870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical, histological, and virological features of hepatitis C virus carriers with persistently normal or abnormal alanine transaminase levels.
    Puoti C; Magrini A; Stati T; Rigato P; Montagnese F; Rossi P; Aldegheri L; Resta S
    Hepatology; 1997 Dec; 26(6):1393-8. PubMed ID: 9397976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural history of hepatitis C virus carriers with persistently normal aminotransferase levels.
    Persico M; Persico E; Suozzo R; Conte S; De Seta M; Coppola L; Palmentieri B; Sasso FC; Torella R
    Gastroenterology; 2000 Apr; 118(4):760-4. PubMed ID: 10734027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histological features and HLA class II alleles in hepatitis C virus chronically infected patients with persistently normal alanine aminotransferase levels.
    Renou C; Halfon P; Pol S; Cacoub P; Jouve E; Bronowicki JP; Arpurt JP; Rifflet H; Picon M; Causse X; Canva V; Denis J; Tran A; Bourliére M; Ouzan D; Pariente A; Dantin S; Alric L; Cartier V; Reville M; Caillat-Zucman S
    Gut; 2002 Oct; 51(4):585-90. PubMed ID: 12235085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HCV carriers with persistently normal ALT Levels: not too much healthy, not true patients.
    Puoti C
    Rom J Gastroenterol; 2004 Dec; 13(4):329-32. PubMed ID: 15624031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of alanine aminotransferase flare-up among asymptomatic hepatitis C virus RNA carriers: a 10-year follow-up study.
    Tsuji K; Yamasaki K; Yamanishi M; Kawakami M; Shirahama S
    J Gastroenterol Hepatol; 2001 May; 16(5):536-40. PubMed ID: 11350550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis C virus carriers with persistently normal ALT levels: biological peculiarities and update of the natural history of liver disease at 10 years.
    Persico M; Perrotta S; Persico E; Terracciano L; Folgori A; Ruggeri L; Nicosia A; Vecchione R; Mura VL; Masarone M; Torella R
    J Viral Hepat; 2006 May; 13(5):290-6. PubMed ID: 16637858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liver biopsy findings for HIV-infected patients with chronic hepatitis C and persistently normal levels of alanine aminotransferase.
    Sánchez-Conde M; Berenguer J; Miralles P; Alvarez F; Carlos Lopez J; Cosin J; Pilar C; Ramirez M; Gutierrez I; Alvarez E
    Clin Infect Dis; 2006 Sep; 43(5):640-4. PubMed ID: 16886160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alanine aminotransferase flare-up in hepatitis C virus carriers with persistently normal alanine aminotransferase levels in a hyperendemic area of Japan.
    Uto H; Kurogi J; Takahama Y; Kusumoto K; Hayashi K; Ido A; Kohara M; Stuver SO; Moriuchi A; Hasegawa S; Oketani M; Tsubouchi H
    J Gastroenterol; 2007 Aug; 42(8):673-80. PubMed ID: 17701131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiviral treatment of HCV carriers with persistently normal ALT levels.
    Puoti C; Bellis L; Galossi A; Guarisco R; Nicodemo S; Spilabotti L; Unto OD
    Mini Rev Med Chem; 2008 Feb; 8(2):150-2. PubMed ID: 18289098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interferon monotherapy for patients with chronic hepatitis C and normal serum aminotransferase levels at commencement of treatment.
    Mamori S; Suzuki F; Hosaka T; Akuta N; Someya T; Kobayashi M; Tsubota A; Suzuki Y; Saitoh S; Arase Y; Ikeda K; Kumada H
    J Gastroenterol; 2004 Aug; 39(8):776-82. PubMed ID: 15338372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis C reactivation in patients with chronic infection with genotypes 1b and 2c: a retrospective cohort study of 206 untreated patients.
    Rumi MG; De Filippi F; La Vecchia C; Donato MF; Gallus S; Del Ninno E; Colombo M
    Gut; 2005 Mar; 54(3):402-6. PubMed ID: 15710990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progressive hepatic fibrosis in healthy carriers of hepatitis C virus with a transaminase breakthrough.
    Rumi MG; De Filippi F; Donato MF; Del Ninno E; Colombo M
    J Viral Hepat; 2002 Jan; 9(1):71-4. PubMed ID: 11851905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis C infection in Alaska Natives with persistently normal, persistently elevated or fluctuating alanine aminotransferase levels.
    Bruce MG; Bruden D; McMahon BJ; Christensen C; Homan C; Sullivan D; Deubner H; Hennessy T; Williams J; Livingston S; Gretch D
    Liver Int; 2006 Aug; 26(6):643-9. PubMed ID: 16842319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A follow-up study to determine the value of liver biopsy and need for antiviral therapy for hepatitis C virus carriers with persistently normal serum aminotransferase.
    Okanoue T; Makiyama A; Nakayama M; Sumida Y; Mitsuyoshi H; Nakajima T; Yasui K; Minami M; Itoh Y
    J Hepatol; 2005 Oct; 43(4):599-605. PubMed ID: 16024129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term histologic improvement and loss of detectable intrahepatic HCV RNA in patients with chronic hepatitis C and sustained response to interferon-alpha therapy.
    Marcellin P; Boyer N; Gervais A; Martinot M; Pouteau M; Castelnau C; Kilani A; Areias J; Auperin A; Benhamou JP; Degott C; Erlinger S
    Ann Intern Med; 1997 Nov; 127(10):875-81. PubMed ID: 9382365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relationship of histologic activity to serum ALT, HCV genotype and HCV RNA titers in chronic hepatitis C.
    Lee YS; Yoon SK; Chung ES; Bae SH; Choi JY; Han JY; Chung KW; Sun HS; Kim BS; Kim BK
    J Korean Med Sci; 2001 Oct; 16(5):585-91. PubMed ID: 11641527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Should we treat HCV carriers with normal ALT levels? The '5Ws' dilemma.
    Puoti C; Guarisco R; Spilabotti L; Bellis L; Mitidieri Costanza O; Dell' Unto O; Elmo MG
    J Viral Hepat; 2012 Apr; 19(4):229-35. PubMed ID: 22404720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationships between serum aminotransferase levels, liver histologies and virological status in patients with chronic hepatitis C in Taiwan.
    Luo JC; Hwang SJ; Lai CR; Lu CL; Li CP; Tsay SH; Wu JC; Chang FY; Lee SD
    J Gastroenterol Hepatol; 1998 Jul; 13(7):685-90. PubMed ID: 9715418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective study on anti-hepatitis C virus-positive patients with persistently normal serum alanine transaminase with or without detectable serum hepatitis C virus RNA.
    Martinot-Peignoux M; Boyer N; Cazals-Hatem D; Pham BN; Gervais A; Le Breton V; Levy S; Degott C; Valla DC; Marcellin P
    Hepatology; 2001 Nov; 34(5):1000-5. PubMed ID: 11679971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.